MediMabs Antibodies, founded in 2006 by McGill University researchers, is strategically headquartered in Montreal, Quebec, Canada. The company emerged to provide local researchers with access to high-quality research antibodies at affordable rates, thereby enhancing research efficiency beyond typical laboratory capabilities.
Positioned within the vibrant Montreal life sciences cluster, MediMabs Antibodies is surrounded by a thriving ecosystem of biotech companies, universities, and healthcare institutions. This advantageous location facilitates partnerships and innovation in the Biopharma and Biotechnology sectors.
The company has expanded its offerings to include a comprehensive "One stop shop" for antibody needs, enhancing its original services with innovative solutions for the Health Care industry. Despite its growth, MediMabs Antibodies has not publicly disclosed recent investments or investor collaborations.